Evidence map›Paper›PMID 37932264›Full record

ArticleNature communications2023

Foxp3 orchestrates reorganization of chromatin architecture to establish regulatory T cell identity.

Zhi Liu, Dong-Sung Lee, Yuqiong Liang, Ye Zheng, Jesse R Dixon

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. FOXP-stabilization of thebioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Zhi Liu *Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dong-Sung Lee *Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID 0000-0003-3815-7057
Yuqiong LiangNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA.
Ye ZhengNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA. yzheng@salk.edu.ORCID 0000-0001-5012-4309
Jesse R DixonGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA. jedixon@salk.edu.ORCID 0000-0002-6273-2181
Salk Institute for Biological Studies · USUniversity of Seoul · KR

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Treg development and function controlled by cis-regulatory circuitsR01AI107027 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ZHENG, YE · 2014 to 2022
$5.0M
The role of BAF related complexes in regulatory T cell development and functionR01AI151123 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HARGREAVES, DIANA CLARE, ZHENG, YE · 2020 to 2024
$4.0M
Investigating the effects of structural variants on 3D genome organization and gene regulation in cancer genomesU01CA260700 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI DIXON, JESSE R · 2020 to 2024
$3.5M
Mechanisms of formation of 3D genome structuresDP5OD023071 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI DIXON, JESSE R · 2016 to 2020
$2.4M
BD FACSAria Fusion for Flow Cytometry Core FacilityS10OD023689 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ZHENG, YE · 2018 to 2018
$530k
Define the role of REV-ERB in colonic RORgt+ regulatory T cellsR21AI178938 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ZHENG, YE · 2023 to 2024
$523k
A novel role of hypusination in controlling regulatory T cell functionR21AI154919 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ZHENG, YE · 2021 to 2022
$523k
NCI NIH HHS P30 CA014195NCI NIH HHS U01 CA260700NIAID NIH HHS R01 AI107027NIAID NIH HHS R01 AI151123NIAID NIH HHS R21 AI154919NIAID NIH HHS R21 AI178938NIH HHS DP5 OD023071NIH HHS S10 OD023689
6 · The paper itself

Abstract

Chromatin conformation reorganization is emerging as an important layer of regulation for gene expression and lineage specification. Yet, how lineage-specific transcription factors contribute to the establishment of cell type-specific 3D chromatin architecture in the immune cells remains unclear, especially for the late stages of T cell subset differentiation and maturation. Regulatory T cells (Treg) are mainly generated in the thymus as a subpopulation of T cells specializing in suppressing excessive immune responses. Here, by comprehensively mapping 3D chromatin organization during Treg cell differentiation, we show that Treg-specific chromatin structures were progressively established during its lineage specification, and highly associated with Treg signature gene expression. Additionally, the binding sites of Foxp3, a Treg lineage specifying transcription factor, were highly enriched at Treg-specific chromatin loop anchors. Further comparison of the chromatin interactions between wide-type Tregs versus Treg cells from Foxp3 knock-in/knockout or newly-generated Foxp3 domain-swap mutant mouse revealed that Foxp3 was essential for the establishment of Treg-specific 3D chromatin architecture, although it was not dependent on the formation of the Foxp3 domain-swapped dimer. These results highlighted an underappreciated role of Foxp3 in modulating Treg-specific 3D chromatin structure formation.

Indexed as

ChromatinT-Lymphocytes, RegulatoryAnimalsCell DifferentiationForkhead Transcription FactorsGene Expression RegulationMiceChromatinForkhead Transcription FactorsFoxp3 protein, mouse

Identifiers

PMID37932264
PMCPMC10628232
OpenAlexW4388412824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.